title: Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome.
authors.forename: Anna
authors.initials: A
authors.lastname: Candoni
authors.forename: Alessandra
authors.initials: A
authors.lastname: Sperotto
authors.forename: Valentina
authors.initials: V
authors.lastname: Tomadini
authors.forename: Carla
authors.initials: C
authors.lastname: Filì
authors.forename: Daniela
authors.initials: D
authors.lastname: Damiani
authors.forename: Renato
authors.initials: R
authors.lastname: Fanin
mesh_terms: D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000628:therapy*; D008297:Male; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012307:Risk Factors; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D016019:Survival Analysis; D020858:Tissue and Organ Harvesting / Q000379:methods; D014182:Transplantation, Autologous / Q000009:adverse effects / Q000379:methods; D016896:Treatment Outcome